Filipino-led biotech firm InterVenn opens Philippine office

·Contributor
·2 min read
Biotech company InterVenn Biosciences has opened a state-of-the-art office at The Podium West Tower in Ortigas Center, Mandaluyong City, Philippines. (Photo: The Podium West Tower)
Biotech company InterVenn Biosciences has opened a state-of-the-art office at The Podium West Tower in Ortigas Center, Mandaluyong City, Philippines. (Photo: The Podium West Tower)

InterVenn Biosciences, a Filipino-founded, San Francisco-based biotech firm, has launched a satellite office in the Philippines on Friday (July 22). The office is just one of the company's several branches launched in different places in the world).

“Our global expansion reflects the significant opportunity to apply glycoproteomics to improve clinical decision-making and translational research on a worldwide scale,” Aldo Carrascoso, InterVenn’s CEO, said.

“Our new offices and laboratory space will enable us to scale our operations, better connect with biomedical hubs, access local talent and serve different regions with localized resources,” Carrascoso added.

Aside from the Philippines, it has also opened its doors on new multiple locations such as in Kuala Lumpur in Malaysia, Melbourne in Australia, and San Diego in Southern California, in order to scale up InterVenn’s “software development, technical support, clinical research and business development.”

The company employs a total of 150 Filipinos here in the Philippines, half of whom are software developers.

The Philippine branch, according to InterVenn, will “allow the company to scale its software engineering and IT capabilities to support current and future development and commercial activities.”

The company’s advanced AI platform was able to help its global groups of researchers and scientists significantly reduce the time it takes to process analysis of samples from months to mere seconds.

“InterVenn has made significant progress in early cancer detection thanks to the brilliant and dedicated Filipino engineers we have on board. They helped build and maintain the front end, back end, and cloud infrastructure of our next-generation liquid biopsy,” Carrascoso further pointed out.

“One hundred percent of our software is proudly Philippine-made. We started this venture with the goal of not just having the means of finding a cure and early detection of cancer, but to also showcase to everyone that we Filipinos can achieve this on a global scale,” said Axel Kornerup, InterVenn Philippines general manager.

Aside from Carrascoso, the two other founders of the company are Dr. Carolyn Betrozzi from Stanford University, and Dr. Carlito LeBrilla of the University of California–Davis.

Marvin Joseph Ang is a news and creative writer who follows developments on politics, democracy, and popular culture. He advocates for a free press and national democracy. Follow him on Twitter at @marvs30ang for latest news and updates.

Watch more videos on Yahoo:

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting